Diabetes Symposium

As COVID-19 transitions from travel-related to community-acquired transmission, we have seen an increase in cases across Maryland and the Washington, D.C., region and anticipate further escalation in the days/weeks ahead. Our commitment to the safety of our patients, associates, physicians, and community remains our top priority.

With this in mind, MedStar Health is temporarily restricting all internal meetings with greater than 50 attendees that are non-essential to the clinical or operational functioning of the entity or organization until further notice.

Following this temporary restriction, the Diabetes XLIII CME on Thursday, April 2 at MedStar Union Memorial Hospital will be canceled. All payments will be refunded. For questions, please contact Lynne Brecker at 410-554-4527.

Welcome to the 43rd Annual Diabetes Symposium

Date: Thursday, April 2, 2020
Time: 7:40 a.m. to 4:45 p.m.

Up to 7.5 CME credits. Breakfast and lunch will be provided.

Who should attend?
Practicing physicians, house officers, physician assistants, nurse practitioners, and other medical personnel who treat or educate patients with diabetes.

For any questions, please contact:
Lynne J. Brecker, RN, BSN, Certified Diabetes Educator at MedStar Union Memorial Hospital
[email protected] | 410-554-4527

MedStar Union Memorial Hospital | Conference Center
201 E. University Parkway, Baltimore, MD 21218

Free parking is available at the Homewood garage, 2614 N Charles Street.
Shuttle service is available.

$150.00 for practicing physicians
$75.00 for house officers, physicians assistants, nurse practitioners and other medical personnel.

Reserve your spot by calling 866-493-1977 to register or register online.
Registration deadline: March 26, 2020

Course participants desiring overnight accommodations should contact the Diabetes and Endocrine Center at MedStar Union Memorial Hospital at 410-554-4527 for suggestions.

Learn more about Diabetes and Endocrinology at MedStar Union Memorial.

Program Schedule

Issam Cheikh, MD, FACP, FACE – Presiding

7:40 a.m.          Registration and Continental Breakfast

8 a.m.               Welcome and Introductory Remarks 
                           Dana H. Frank, MD

8:05 a.m.          Updates on Diabetes—43 years
                           Issam E. Cheikh, MD

8:40 a.m.         Diabetes Diagnosis and Treatment in the Age of Precision Medicine
                          Alan Shuldiner, MD

9:30 a.m.         Etiology of Type 2 Diabetes
                          Ralph A. DeFronzo, MD

10:20 a.m.       Coffee Break

10:40 a.m.       Beyond Hemoglobin A1c: Better Measures of Diabetes Control
                          Pamela R. Schroeder, MD, PhD

11:20 a.m.       Eye Disease in Diabetes  
                         Maria S. Romero, MD            

Mansur Shomali, MD – Presiding

12:05 p.m.     Lunch Break  

1:05 p.m.       Improving Cardiac and Renal Outcomes Utilizing SGLT2 Inhibitor
                        Sevil Aliyeva, MD

1:45 p.m.       Nonglycemic Effects of GLP1 Agonists
                        Rani S. Kulkarni, MD

2:25 p.m.       Diabetes and Bone Health
                        Malek E. Cheikh, MD

3:05 p.m.       Beyond Basal Insulin—What to Add Next
                        Paul A. Sack, MD

3:45 p.m.      How Data and Technology are Transforming Diabetes Care
                       Mansur E. Shomali, MD

4:30 p.m.       Summary and Closing Remarks
                       Issam E. Cheikh, MD

4:45 p.m.      Adjourn

Meet the Speakers

Sevil Aliyeve, MD
Senior Fellow, Division of Endocrinology and Metabolism
MedStar Union Memorial Hospital

Issam E. Cheikh, MD, FACP, FACE
Chief, Division of Endocrinology and Metabolism
Director, Diabetes and Endocrine Center
MedStar Union Memorial Hospital
Adjunct Professor of Medicine
University of Maryland School of Medicine

Malek E. Cheikh, MD
Division of Endocrinology and Metabolism
MedStar Union Memorial Hospital
Director, Good Health Center
MedStar Good Samaritan Hospital

Ralph A. DeFronzo, MD
Professor of Medicine
Chief, Diabetes Division
UT Health San Antonio
San Antonio, TX

Dana H. Frank, MD, FACP
Chairman, Department of Medicine
MedStar Union Memorial Hospital and
MedStar Good Samaritan Hospital
Assistant Professor
Johns Hopkins University School of Medicine

Rani S. Kulkarni, MD
Division of Endocrinology and Metabolism
MedStar Union Memorial Hospital
MedStar Harbor Hospital

Maria Romero, MD
Physician CEO
Precision Eye Care
Baltimore, MD

Paul  A. Sack, MD, FACE
Assistant Chief, Division of Endocrinology and Metabolism
Co-director, Thyroid Clinic
MedStar Union Memorial Hospital
Clinical Assistant Professor of Medicine
University of Maryland School of Medicine

Pamela R. Schroeder, MD, PhD, FACE
Program Director, Endocrinology Fellowship
MedStar Union Memorial Hospital
Co-Director, Thyroid Clinic
MedStar Union Memorial Hospital
Assistant Professor, Division of Endocrinology
Johns Hopkins University School of Medicine

Mansur E. Shomali, MD, C.M.
Division of Endocrinology and Metabolism
MedStar Union Memorial Hospital
Medical Director, WellDoc, Inc
Adjunct Associate Professor of Medicine
University of Maryland School of Medicine

Alan R. Shuldiner, MD
John L. Whitehurst Professor of Medicine
University of Maryland
Director, Program in Personalized and Genomic Medicine
Vice President, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc.


Planning Committee
The topics for Update on Diabetes XLIII were selected to update the attendees on the latest scientific data and clinical applications for the research of diabetes.  The program was assembled by Dr. Issam E. Cheikh and the Endocrinology faculty at MedStar Union Memorial Hospital.

Course Goals and Objectives 

Target Audience
This program is designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information on the treatment of diabetes. The program is targeted for hospital-based physicians, community physicians, fellows, residents, medical students, nurse practitioners, physician assistants, nurses, pharmacists, dietitians/nutritionists, and other members of the healthcare team who have an interest in the treatment of diabetes.

Learning Objectives
Upon completion of this program, participants will be able to:

  1. Appreciate the improvement of diabetes care over the past half century.
  2. Discuss both opportunities and challenges of precision medicine and how this new paradigm may lead to better individualized treatment of Type 2 diabetes.
  3. Review the pathophysiology of Type 2 diabetes with an emphasis on optimal treatment.
  4. Identify blood glucose metrics such as average glucose and time in range to select and adjust therapies on an individual basis.
  5. Describe various ophthalmic conditions likely to be encountered in patients with diabetes, with a focus on diabetic retinopathy, screening methods, and interpretation of reports.
  6. Review the evidence supporting the cardiovascular safety of SGLT2 inhibitors to better assess strategies that can reduce risk of cardiovascular and kidney disease in patients with Type 2 diabetes.
  7. Identify how to use GLP-1 agonist therapies for patients with Type 2 diabetes at increased risk for cardiovascular disease to achieve guideline recommended targets for glycemic, lipid, and blood pressure control.
  8. Explain the link between diabetes and bone disease and the effect of diabetes therapy on bone strength.
  9. Recognize the risks and benefits of adding meal time insulin versus non-insulin therapies for patients with uncontrolled Type 2 diabetes on basal insulin alone.
  10. Express how members of the health care team can integrate data and evidence-based technology tools in clinical practice to improve diabetes care.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedStar Health.  MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 7.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

MedStar Union Memorial Hospital reserves the right to cancel any educational program due to unforeseen circumstances. 

The topics for Update on Diabetes XLIII were chosen to give an overview of advances in diabetes care.  The faculty of this program has been selected from national and local experts for their ability to present complicated and new information clearly and authoritatively.  After this activity, the knowledge gained from attending this symposium will enable attendees to improve the care of  patients with diabetes.